Quiet Therapeutics

Quiet Therapeutics Ltd.Founded in 2009, Quiet Therapeutics Ltd. focuses on domain sales and leasing. The company's headquarters are located in Israel, and it has completed 2 deals since its inception.Quiet Therapeutics Ltd. specializes in the sale and leasing of premium domain names, offering a streamlined and secure purchasing process for clients in need of a digital identity. The company’s core offerings include a one-time purchase option for domains, a lease-to-own model allowing for monthly payments, and an opportunity for potential buyers to submit offers. These services cater to a diverse clientele ranging from small startups to established corporations across various industries seeking to enhance their online presence. The company operates in multiple geographical markets, focusing on regions with robust digital economies, including North America, Europe, and parts of Asia.The revenue model for Quiet Therapeutics Ltd. is primarily driven by domain sales and leasing arrangements with customers. The company generates income through direct transactions, where clients can either purchase a domain outright for a set price or opt for the lease-to-own structure, which typically involves monthly payments.com could choose to pay the full price of USD 49,850 or select the lease option at USD 1,081 per month, allowing flexibility based on their financial strategy. The transaction structure is set up to accommodate both business-to-consumer (B2C) and business-to-business (B2B) relationships, providing a versatile platform for different types of clients.Future growth plans for Quiet Therapeutics Ltd. include the development of new premium domain offerings and the exploration of additional leasing models.

1. Series A

   Apr 12, 2015

   Amount

   $12M

   Investors

   Locked